Boltz

United States · Biotech · AI

Boltz builds biomolecular AI models and software for molecular design and drug-discovery research.

Models for molecular discovery

Boltz develops foundation models for biology and chemistry. Scientists use its software to predict molecular structures, design proteins and small molecules, and explore potential drug candidates. Its products include the Boltz Lab platform, an API and open-source models.

The company supports pharmaceutical and biotechnology research teams integrating these models into existing discovery workflows. Its deployment options and custom-model work allow researchers to apply proprietary scientific data to molecular design.

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
Planned strategic investmentUndisclosedNVIDIA — Participant
Sourcesboltz.com ↗boltz.com ↗